GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Dividend per Share (DPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| DPS(Rs) | 57.00 | 54.00 | 32.00 | 32.00 | 90.00 |
What is the latest Dividend per Share (DPS) ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Dividend per Share (DPS) |
|---|---|
| Mar2026 | 57.00 |
| Mar2025 | 54.00 |
| Mar2024 | 32.00 |
| Mar2023 | 32.00 |
| Mar2022 | 90.00 |
How is Dividend per Share (DPS) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Dividend per Share (DPS) | % Change | |
|---|---|---|---|
| Mar2026 | 57 | 5.56 | |
| Mar2025 | 54 | 68.75 | |
| Mar2024 | 32 | 0.00 | |
| Mar2023 | 32 | -64.44 | |
| Mar2022 | 90 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Dividend per Share (DPS) ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹50,090.7 Cr | -1.3% | 14% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -1.3% |
14% |
7.6% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses